An angiogenic growth factor produced by tumor cells. It is able to induce specific malignant characteristics in normal cells (such as fibroblasts), thereby “transforming” those cells. TGF-alpha appears to possess a variety of potentially useful pharmaceutical properties, such as powerful stimulation of scar tissue formation following wounding of a tissue, as indicated by preliminary research.